trolamine salicylate has been researched along with Malaria, Falciparum in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Deme, H; Diack, ND; Diallo, MA; Dieng, M; Diongue, K; Djiba, B; Kane, BS; Ndiaye, D; Pouye, A; Sow, M | 1 |
Bilia, AR; Casini, A; Gabbiani, C; Majori, G; Messori, L; Sannella, AR; Severini, C; Vincieri, FF | 1 |
2 other study(ies) available for trolamine salicylate and Malaria, Falciparum
Article | Year |
---|---|
Tuberculosis arthritis of the sternoclavicular joint after uncomplicated falciparum malaria: a case report.
Topics: Antimalarials; Antitubercular Agents; Arthritis; Female; Humans; Malaria, Falciparum; Mycobacterium tuberculosis; Plasmodium falciparum; Sternoclavicular Joint; Tuberculosis; Young Adult | 2017 |
New uses for old drugs. Auranofin, a clinically established antiarthritic metallodrug, exhibits potent antimalarial effects in vitro: Mechanistic and pharmacological implications.
Topics: Animals; Antimalarials; Antirheumatic Agents; Arthritis; Auranofin; Humans; Malaria, Falciparum; Plasmodium falciparum | 2008 |